Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.

Li Tang,Diego R. Hijano,Aditya H. Gaur,Terrence L. Geiger,Ellis J. Neufeld,James M. Hoffman,Randall T. Hayden

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.

2021

Li Tang
Diego R. Hijano
Aditya H. Gaur
Terrence L. Geiger
Ellis J. Neufeld
James M. Hoffman
Randall T. Hayden

This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.

Keywords:

Virology
Vaccination
Coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
Workforce
Asymptomatic
2019 20 coronavirus outbreak
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations